Announcement: The National Institutes of Health (NIH) has recently updated their Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients website with a number of additional FAQs, new funding opportunities, as well as a video message addressing some of the most common questions. Since the recording of the video, in response to community concerns […]
Announcements
DOD Issues FAQs for Proposers and Awardees Impacted by COVID-19
Announcement: The Department of Defense (DOD) has issued a notice regarding Frequently Asked Questions for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19). Please review the below summary: Extension of Due DatesThe DOD will allow grantees to delay submission of financial, performance and other reports on currently-active award accounts up to three […]
Minimum Level of Effort for NCI-Funded Awards
Announcement: The National Cancer Institute (NCI) released a notice requiring a minimum level of effort for funding consideration for NCI-funded grants. In addition to previously established policies for specific grant mechanisms described in funding opportunity announcements (FOAs), Principal Investigators (PIs), including Project Leaders on multi-project grants, will be required to commit a minimum level of […]
NSF Implementation of OMB Memo M-20-17 – Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus due to Loss of Operations
Announcement:The National Science Foundation (NSF) has issued important guidance to the community regarding COVID-19: Important Notice No 146 to the Community Regarding COVID-19 Guidance on NSF’s implementation of the Office of Management and Budget (OMB) Memorandum (M-20-17) Please review the above guidance, in addition to the below summary of the flexibilities that NSF is implementing […]
Guidance for NIH-Funded Clinical Trials and Human Subjects Studies Affected by COVID-19
Announcement: The National Institutes of Health (NIH) has released a notice detailing expanded flexibilities related to NIH-Funded clinical trials and human subjects studies affected by COVID-19. At this time, NIH encourages recipients to consult with their IRB and institutions about potential measures to protect participants and research staff. Examples of such measures are: Limiting study […]
Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
Announcement: The National Institutes of Health (NIH) has issued a notice to alert the research community of administrative flexibilities that will apply to NIH applicants and recipients. Therefore, working with the Office of Management and Budget (OMB) and the Department of Health and Human Services (HHS) NIH has identified the following short-term administrative flexibilities to […]